Synthesa
Synthesa is an AI-powered evidence synthesis firm that combines a proprietary NLP and machine learning engine with human domain expertise to deliver PRISMA-compliant systematic reviews, meta-analyses, and health technology assessments to pharmaceutical, biotech, medical device, and academic clients.
- Company typePrivate
- Founded2025
- HeadquartersNew York, United States
- Headcount1–10
- GTM typeB2B
- OfferingServices
What Synthesa does
Synthesa is an AI-powered evidence synthesis services firm headquartered at 19 West 24th Street, New York that delivers systematic reviews, meta-analyses, network meta-analyses, meta-regression analyses, and health technology assessments to healthcare and pharmaceutical organizations. The company's offering combines a proprietary AI engine—built on natural language processing and machine learning—with human domain expertise, in which experienced research professionals lead and supervise all deliverables to maintain PRISMA-compliant scientific rigor while compressing project timelines from months to days. Modality coverage spans unstructured scientific text (literature screening, data extraction, qualitative synthesis) and structured tabular/time-series data (meta-analytic statistical modeling), positioning the platform across both the qualitative and quantitative ends of the evidence synthesis workflow.
The core product surface consists of four services: PRISMA-compliant Systematic Reviews & Meta-Analyses, Network Meta-Analysis (Bayesian and Frequentist frameworks for hierarchical treatment ranking), Meta-Regression Analysis (exploration of study-level heterogeneity), and Health Technology Assessments. All work runs through a custom AI engine specifically designed for healthcare literature rather than adapted from a generic LLM, supported by an advisory bench that includes a globally cited interventional cardiologist (h-index 122, 1,100+ publications) and a PhD machine learning researcher with publications at EMNLP and ACL.
Commercially, Synthesa operates an enterprise field sales motion with no publicly disclosed pricing; customer acquisition is driven through free-consultation and custom-quote CTAs, a content-led Insights Hub, LinkedIn, and a newsletter/wait list. Target customers are pharmaceutical and biotech firms (rapid literature reviews for R&D and product roadmaps), medical device manufacturers (validation and compliance documentation), MedComms agencies and CROs (client-deliverable scalability), and academic researchers (grant-grade systematic reviews). Three named enterprise customers are disclosed—Centaur Clinical, Samsara Vision, and Pari—alongside an anonymized testimonial from a German medical device manufacturer. The firm claims a worldwide service footprint despite a 1–10 person team and has no API, SDK, or disclosed platform integrations, confirming a professional services delivery model rather than a self-serve SaaS product.
Synthesa firmographics
Firmographics- Name
- Synthesa
- Legal name
- Synthesa, Inc.
- Website
- https://synthesa.ai
- Company type
- Private
- Founded year
- 2025
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Synthesa is an AI-powered evidence synthesis firm that combines a proprietary NLP and machine learning engine with human domain expertise to deliver PRISMA-compliant systematic reviews, meta-analyses, and health technology assessments to pharmaceutical, biotech, medical device, and academic clients.
- Ownership category
- akta.pro rank
Synthesa industry classification
Industry- Product category
- Healthcare Evidence Synthesis Services
- NAICS
- Scientific Research and Development Services (5417), Computer Systems Design and Related Services (54151)
- SIC
- Services-Management Consulting Services (8742), Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Generative AI & LLM Solutions Services (RAG, Agents, Copilots) (BPAEAHAG)
- akta.pro secondary industry
- AI/ML Platforms for Drug Discovery & Experiment Optimization (HLAGAJAO)
Keywords
Where Synthesa is headquartered
LocationHeadquarters
- HQ city
- New York
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Synthesa business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations
Revenue model
- Evidence Synthesis Services: Professional services revenue from providing systematic reviews, meta-analyses, network meta-analyses, and meta-regression analyses to healthcare and pharma clients. Services are tailored to client-specific needs with expert supervision.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels3 records
Synthesa product offering
Product offeringCore offering
Synthesa delivers AI-powered evidence synthesis services for healthcare and pharmaceutical clients, producing systematic reviews, meta-analyses, network meta-analyses, meta-regression analyses, and health technology assessments. A custom AI engine combining natural language processing and machine learning accelerates literature screening and data extraction, while experienced clinical researchers supervise all deliverables to ensure PRISMA-compliant scientific rigor and faster turnaround than traditional manual workflows.
Product overview
Synthesa is an AI-powered evidence synthesis platform that combines custom AI technology with human domain expertise to deliver systematic reviews, meta-analyses, and health technology assessments. The platform consists of core service offerings including Systematic Reviews & Meta-Analyses (PRISMA-compliant literature synthesis), Network Meta-Analysis (simultaneous multi-intervention comparison using Bayesian and Frequentist approaches), and Meta-Regression Analysis (advanced statistical modeling for exploring study-level heterogeneity). All services are led and supervised by experienced research professionals who guarantee accuracy of deliverables.
Differentiator
Problem solved
Functional benefit
Products and services
- Systematic Reviews and Meta-Analyses
Companies that use Synthesa
Customer profileNamed customers3 records
Segments4 records
Ideal customer profiles4 records
Synthesa technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability4 records
Feature2 records
Synthesa partnerships and signals
Strategic signalScale indicators1 record
Recent moves6 records
Expansion highlights5 records
Synthesa competitors and assessment
Company assessmentDirect peers
- Elicit: AI research assistant that uses LLMs to find, summarize, and extract data from scientific papers. Most directly comparable AI-native evidence synthesis tool targeting researchers and evidence synthesis workflows.
- Consensus: AI-powered academic search engine that synthesizes findings from peer-reviewed studies. Directly competes in the AI-enabled literature synthesis category serving researchers and analysts.
- DistillerSR (Evidence Partners): Established systematic review management software used by pharma, medtech, and academic institutions to manage literature reviews. Closest incumbent in the systematic review workflow tool category.
- Covidence: Standard systematic review production platform used widely by Cochrane reviewers and academic institutions. Directly comparable workflow tool for screening, data extraction, and PRISMA-compliant reviews.
- Rayyan: AI-assisted systematic review platform for screening and collaboration, widely used by academic and pharma teams. Directly comparable in the AI-powered systematic review workflow category.
- Nested Knowledge: Evidence synthesis and visualization platform combining literature review with structured outputs. Comparable AI-enabled synthesis workflow for medical and health economics research.
Broad incumbents
- Cochrane: Global nonprofit and gold standard in systematic reviews. Sets the methodological benchmark (PRISMA, GRADE) that Synthesa's deliverables must meet, and represents the entrenched institutional alternative Synthesa must displace.
- IQVIA: Global CRO and health data giant offering evidence synthesis, HTA, and real-world evidence services to pharma. Represents the large incumbent competitor with deep pharma procurement relationships and could absorb AI-driven evidence synthesis as a feature.
- Clarivate: Provider of scientific and intellectual property data, including literature databases and analytics tools used by pharma and academic systematic reviewers. Comparable as a broader analytics incumbent with overlapping evidence synthesis workflows.
Emerging players
- Scite: AI tool that classifies scientific citations as supporting or contradicting. Adjacent to evidence synthesis by providing structured, evidence-graded insight from the scientific literature for similar buyer personas.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat3 records
Key risks6 records
Key highlights6 records
Customer concentration
Synthesa social profiles
Digital presenceSynthesa financial estimates
Financial estimateRevenue estimate
Valuation estimate
Synthesa leadership team
Management profileNumber of profiles
Profiles5 records
Synthesa funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Synthesa M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Synthesa
What does Synthesa do?
Synthesa delivers AI-powered evidence synthesis services for healthcare and pharmaceutical clients, producing systematic reviews, meta-analyses, network meta-analyses, meta-regression analyses, and health technology assessments. A custom AI engine combining natural language processing and machine learning accelerates literature screening and data extraction, while experienced clinical researchers supervise all deliverables to ensure PRISMA-compliant scientific rigor and faster turnaround than traditional manual workflows.
Is Synthesa a public or private company?
Synthesa is a private company. It is classified as unknown and is currently operating.
When was Synthesa founded?
Synthesa was founded in 2025. It employs 1 to 10 people.
Where is Synthesa based?
Synthesa is headquartered in New York, United States, in the North America region.
How does Synthesa make money?
One revenue line is on record: evidence Synthesis Services.
Who are Synthesa's main competitors?
Direct peers on record are Elicit, Consensus, DistillerSR (Evidence Partners), Covidence, Rayyan and Nested Knowledge. Broad incumbents are Cochrane, IQVIA and Clarivate. Scite is listed as an emerging player.
Does Synthesa have an API?
No public API is recorded for Synthesa.
What industry is Synthesa in?
Synthesa's product category is Healthcare Evidence Synthesis Services. Its primary akta.pro industry code is BPAEAHAG, Generative AI & LLM Solutions Services (RAG, Agents, Copilots), with a secondary code of HLAGAJAO, AI/ML Platforms for Drug Discovery & Experiment Optimization. Its NAICS code is 5417 and its SIC code is 8742.